EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Update of Phenotypic–Genotypic IMNEPD Cases and a Bioinformatics Analysis of the New PTRH2 Gene Variants

Rajech Sharkia iD, Marie-Laure Vuillaume iD, Sahil Jain iD, Muhammad Mahajnah iD, Radka Stoeva, Agnès Guichet, Estelle Colin, Jérome Champ, Nicolas Derive iD, Arnaud Chefdor, Abdelnaser Zalan iD

Genes · 2024

DOI: 10.3390/genes15121508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Rajech Sharkia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Human Biology and Genetics, The Triangle Regional Research and Development Center, Kafr Qari 3007500, Israel. Hauptthemen laut MEDLINE: Computational Biology, Carboxylic Ester Hydrolases, Mitochondrial Proteins. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: limited internal resources from the Triangle Research and Development Center (TRDC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Biallelic mutations in the PTRH2 gene are associated with a rare genetic disease known as infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD). In this study, we describe a new case carrying a previously identified mutation, provide an updated analysis of the relative frequencies of the clinical features across all published cases (including the three latest studies), and perform a bioinformatics analysis of the newly identified PTRH2 protein variants from a structural perspective.

Methods

Clinical examination of the patients was carried out, and genetic testing was performed using a genome sequencing strategy. A bioinformatics analysis was carried out for the newly reported mutations using PYMOL that was utilized to view the structure and analyze the mutations. Additionally, the ThermoMPNN webserver was employed to check the effect of point mutations on the overall stability of the protein.

Results

Our findings indicate that motor delay, neuropathy, intellectual disability, distal weakness, hearing impairment, and ataxia are the most common symptoms, while the other clinical features fall into two frequency categories: moderately common ones and the least common ones. The bioinformatics analysis revealed that the Q85 residue is highly conserved, suggesting that mutations at this position could disrupt key signaling pathways or cellular functions. Indeed, the Q85R mutation was shown to significantly impair the stability and functionality of the protein.

Conclusions

The clinical presentation of IMNEPD remains highly variable in terms of both severity and progression. Mutations at the Q85 residue have been identified in nearly 50% of reported cases, highlighting this position as a potential mutational hotspot in the PTRH2 protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computational BiologyCarboxylic Ester HydrolasesMitochondrial ProteinsFemaleHumansInfantMaleGenotypeMembrane ProteinsMutationPancreatic DiseasesPhenotype

Stichwörter der Autor:innen

IMNEPDPTRH2 genePTRH2 variantsautosomal recessive disorderbioinformatics analysisclinical featuresrare genetic diseases

Substanzen

Membrane ProteinsPTH2 protein, humanCarboxylic Ester HydrolasesMitochondrial Proteins

Autor:innen und Institutionen

  • Unit of Human Biology and Genetics, The Triangle Regional Research and Development Center, Kafr Qari 3007500, Israel.
  • Unit of Natural Sciences, Beit-Berl Academic College, Beit-Berl 4490500, Israel.
  • Genetics Department, Tours University Hospital, 37044 Tours, France.
  • INSERM, Imaging Brain & Neuropsychiatry iBraiN U12523, University of Tours, 37032 Tours, France.
  • Bioinformatics Centre, Dr. D.Y. Patil Biotechnology and Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune 411033, India.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109600, Israel.

ORCID-Profile: Rajech Sharkia, Marie-Laure Vuillaume, Sahil Jain, Muhammad Mahajnah, Nicolas Derive, Abdelnaser Zalan

Förderung

  • limited internal resources from the Triangle Research and Development Center (TRDC)

Zitieren

APA

Sharkia, R., Vuillaume, M. L., Jain, S., Mahajnah, M., Stoeva, R., Guichet, A., Colin, E., Champ, J., Derive, N., Chefdor, A., & Zalan, A. (2024). An Update of Phenotypic–Genotypic IMNEPD Cases and a Bioinformatics Analysis of the New PTRH2 Gene Variants. Genes. https://doi.org/10.3390/genes15121508

Vancouver

Sharkia R, Vuillaume ML, Jain S, Mahajnah M, Stoeva R, Guichet A, et al. An Update of Phenotypic–Genotypic IMNEPD Cases and a Bioinformatics Analysis of the New PTRH2 Gene Variants. Genes. 2024. doi:10.3390/genes15121508

BibTeX
@article{Sharkia2024,
  author = {Sharkia, Rajech and Vuillaume, Marie-Laure and Jain, Sahil and Mahajnah, Muhammad and Stoeva, Radka and Guichet, Agnès and Colin, Estelle and Champ, Jérome and Derive, Nicolas and Chefdor, Arnaud and Zalan, Abdelnaser},
  title = {An Update of Phenotypic–Genotypic IMNEPD Cases and a Bioinformatics Analysis of the New PTRH2 Gene Variants},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15121508}
}
Kostenlos starten →